Prevention of status epilepticus-induced brain edema and neuronal cell loss by repeated treatment with high-dose levetiracetam

Brain Research

Volumn 1608, Issue , 2015, Pages 225-234

  Itoh, Kouichi ^a   Inamine, Moriyoshi ^a   Oshima, Wataru ^a   Kotani, Masaharu ^b   Chiba, Yoichi ^c   Ueno, Masaki ^c   Ishihara, Yasuhiro ^d  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b OHU UNIVERSITY   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Brain edema; Epileptogenesis; Levetiracetam; MRI; Pilocarpine; Status epilepticus

Indexed keywords

DIAZEPAM; ETIRACETAM; ANTICONVULSIVE AGENT; MUSCARINIC AGENT; PILOCARPINE; PIRACETAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CELL LOSS; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DRUG MEGADOSE; EPILEPTIC STATE; INCIDENCE; LIMBIC CORTEX; MALE; MORTALITY; MOUSE; NERVE CELL; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; ANALOGS AND DERIVATIVES; ANIMAL; CELL DEATH; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; PATHOLOGY; TIME;

MURINAE;

ANIMALS; ANTICONVULSANTS; BRAIN EDEMA; CELL DEATH; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED ICR; MUSCARINIC AGONISTS; NEURONS; PILOCARPINE; PIRACETAM; STATUS EPILEPTICUS; TIME FACTORS;

EID: 84926257084     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.03.005     Document Type: Article

References (45)

1. C. Brandt, M. Glien, A.M. Gastens, M. Fedrowitz, K. Bethmann, H.A. Volk, H. Potschka, and W. Löscher Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats Neuropharmacology 53 2007 207 221
2. E.A. Cavalheiro, N.F. Santos, and M.R. Priel The pilocarpine model of epilepsy in mice Epilepsia 37 1996 1015 1019
3. G. Curia, D. Longob, G. Biaginib, R.S.G. Jonesc, and M. Avoli The pilocarpine model of temporal lobe epilepsy J. Neurosci. Methods 172 2008 143 157
4. S. Danjo, Y. Ishihara, M. Watanabe, Y. Nakamura, and K. Itoh Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase Brain Res. 1530 2013 44 53
5. L.S. Deshpande, and R.J. DeLorenzo Mechanisms of levetiracetam in the control of status epilepticus and epilepsy Front. Neurol. 5 2014 11 10.3389/fneur.2014.00011
6. J.J. Donkin, and R. Vink Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments Curr. Opin. Neurol. 23 2010 293 299
7. F.E. Dudek, E.H. Bertram, and K.J. Staley Antiepileptogenesis therapy with levetiracetam: data from kindling versus status epilepticus models Epilepsy Curr. 8 2008 28 30
8. J. Engel Jr. Introduction to temporal lobe epilepsy Epilepsy Res. 26 1996 141 150
9. J.E. Gibbs, M.C. Walker, and H.R. Cock Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus Epilepsia 47 2006 469 478
10. M. Glien, C. Brandt, H. Potschka, and W. Löscher Effects of the novel antiepileptic drug Levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy Epilepsia 43 2002 350 357
11. S. Hama, Y. Ishihara, M. Masatomo Watanabe, S. Danjo, Y. Nakamura, and K. Itoh Effects of sulfaphenazole after collagenase-induced experimental intracerebral hemorrhage in rats Biol. Pharm. Bull. 35 2012 1849 1853
12. D.C. Hesdorffer, G. Logroscino, G. Cascino, J.F. Annegers, and W.A. Hauser Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus Ann. Neuol. 44 1998 908 912
13. H. Ichikawa, and K. Itoh Blood-arachnid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging Brain Res. 1390 2011 142 149
14. P.H. Iffland II, G.A. Grant, and D. Janigro Mechanisms of cerebral edema leading to early seizures after traumatic brain injury E.H. Lo, J. Lok, M. Ning, M. Whalen, Vascular mechanisms in CNS trauma, Springer series in Translational Stroke Research 5 2014 Springer Science Business Media New York 29 45
15. M.P. Jacobs, G.G. Leblanc, A. Brooks-Kayal, F.E. Jensen, D.H. Lowenstein, J.L. Noebels, J.L. Noebels, D.D. Spencer, and J.W. Swann Curing epilepsy: progress and future directions Epilepsy Behav. 14 2009 4384 4445
16. P. Kwan, and M.J. Brodie Early identification of refractory epilepsy N. Engl. J. Med. 342 2000 314 319
17. I. Klatzo Pathophysiological aspects of brain edema Acta Neuropathol. (Berl) 72 1987 236 239
18. P. Klein, D. Herr, P.L. Pearl, J. Natale, Z. Levine, C. Nogay, F. Sandoval, S. Trzcinski, S.M. Atabaki, T. Tsuchida, J. van den Anker, S.J. Soldin, J. He, and R. McCarter Results of phase II safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy Arch. Neurol. 9 2012 1 6
19. H. Klitgaard, and A. Pitkanen Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam Epileptic Disord. 5 2003 S9 S16
20. G.T. Manley, M. Fujimura, T. Ma, N. Noshita, F. Filiz, A.W. Bollen, P. Chan, and A.S. Verkman Aquapolin-4 deletion in mice reduces brain edema after acute intoxication and ishemic stroke Nat. Med. 6 2000 159 163
21. E.M. Manno Status epilepticus: current treatment strategies The Neurohospitalist 1 2011 23 31
22. C.A. Massey, L.P. Sowers, B.J. Dlouhy, and G.B. Richerson Mechanisms of sudden unexpected death in epilepsy: the pathway to prevention Nat. Rev. Neurol. 10 2014 271 282
23. A.M. Mazarati, R. Baldwin, H. Klitgaard, A. Matagne, and C.G. Wasterlain Anticonvulsant effects of levetiracetam and levetiracetam diazepam combinations in experimental status epilepticus Epilepsy Res. 58 2004 167 174
24. S. Nag, J.L. Manias, and D.J. Stewart Pathology and new players in the pathogenesis of brain edema Acta Neuropathol. 118 2009 197 217
25. M. Lévesque, C. Behr, and M. Avoli The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy Seizure 25 2015 18 25
26. D. Liang, S. Bhatta, V. Gerzsnich, and J.M. Simard Cytotoxic edema: mechanisms of pathological cell swelling Neurosurg Focus 22 E2 2007 1 9
27. W. Löscher, D. Hönack, and C. Rundfeldt Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy J. Pharmacol. Exp. Ther. 284 1998 474 479
28. K.A. Lyseng-Williamson Levetiracetam: a review of its use in epilepsy Drugs 71 2011 489 514
29. G. Paxions, and K.B.J. Franklin Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates Fourth Edition 2012 Academic Press New York
30. P.L. Pearl, R. McCarter, C.L. McGavin, Y. Yu, F. Sandoval, S. Trzcinski, S.M. Atabaki, T. Tsuchida, J. van den Anker, J. He, and P. Klein Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy Epilepsia 54 2013 e135 e137
31. A. Pitkanen, R.J. Immonen, O.H. Grohn, and I. Kharatishvili From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options Epilepsia 50 2009 21 29
32. R.J. Racine Modification of seizure activity by electrical stimulation: II. Motor seizure Electroencephalogr. Clin. Neurophysiol. 3 1972 281 294
33. A. Righini, C. Pierpaoli, J.R. Alger, Di, and G. Chiro Brain parenchyma apparent diffusion coefficient alterations associated with experimental complex partial status Magn. Reson. Imaging 12 1994 865 871
34. T.P.L. Roberts, and M.D. Noseworthy Contrast agents for magnetic resonance imaging, dynamic contrast-enhanced magnetic resonance imaging in oncology A. Jackson, D.L. Buckley, G.J.M. Parker, Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology 2005 Springer Berlin Heidelberg 23 37
35. H. Shibley, and B.N. Smith Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice Epilepsy Res. 49 2002 109 120
36. Societas Neurologica Japonica, 2010. In Guideline for epilepsy diagnose and treatment in Japan. Igaku-Shoin Ltd., Tokyo, Japan
37. S.C. Stratton, C.H. Large, B. Cox, G. Davies, and R.M. Hagan Antiepileptogenic like effects of lamotrigine in a rat amygdala kindling model Epilepsy Res. 53 2003 95 106
38. L. Turski, C. Ikonomidou, W.A. Turski, Z.A. Bortolotto, and E.A. Cavalheiro Review: cholinergic mechanisms and epileptogenesis: the seizures induced by pilocarpine: a novel experimental model of intractable epilepsy Synapse 3 1989 154 171
39. N.R. Temkin Antiepileptogensis and seizure prevention trials with antiepileptic drugs. Meta-analysis of controlled trials Epilepsia 42 2001 515 524
40. N.R. Temkin Risk factors for posttraumatic seizures in adults Epilepsia 44 2003 18 20
41. N.R. Temkin Preventing and treating posttraumatic seizures: the human experience Epilepsia 50 2009 10 13
42. E. Trinka What is the evidence to use new intravenous AEDs in status epilepticus? Epilepsia 52 2011 35 38
43. Y. Wang, A. Majors, I. Najm, M. Xue, Y. Comair, M. Modic, and T.C. Ng Postictal alteration of sodium content and apparent diffusion coefficient in epileptic rat brain induced by kainic acid Epilepsia 37 1996 1000 1006
44. M. Watanabe, A. Miyai, S. Danjo, Y. Nakamura, and K. Itoh The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains Exp. Neurol. 247 2013 645 652
45. Y. Zheng, J. Moussally, S.S. Cash, H.B. Karnam, and A.J. Cole Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies Neuropharmacology 58 2010 793 798